The five-year results come from a phase 2b study that tested intismeran autogene in combination with Merck’s Keytruda in ...

"Our mission is to create both strategic and financial returns by backing scalable technologies that can transform how biopharma operates.” Bill Taranto, president and general partner of the Merck ...

Merck & Co. will build a $3 billion pharmaceutical manufacturing facility in Elkton, Va. The new site is expected to create 500 jobs, Virginia Gov. Glenn Youngkin and the company announced at a ...

Merck MRK-0.92%decrease; red down pointing triangle is in talks to acquire Revolution Medicines RVMD-0.99%decrease; red down pointing triangle in a deal that could value it at around $30 billion, ...

(MENAFN- GetNews) The Key KRAS Inhibitors Companies in the market include - Pfizer, Roche/Chugai/Genentech, Revolution Medicines, Eli Lilly and Company, Merck, Taiho ...

WALB is working to produce a video for this story. In the meantime, we encourage you to watch our livestream. ALBANY, Ga. (WALB) - Merck is asking a Georgia court to dismiss a lawsuit tied to the ...

With $10 billion pledged to beef up its U.S. operations through 2035, AbbVie has already unveiled plans for a new drug ingredient plant in its home state of Illinois and an expansion of its ...

Officials at the world’s busiest airport said their equipment is ready to treat the runways and areas where planes and vehicles move around.

From eradicating smallpox to battling the COVID-19 pandemic, these vaccine pioneers have helped make colossal strides in public health.

Third-party releases are a common and important component of plans of reorganizations. Key bankruptcy case constituencies have historically relied upon third-party ...